The use of erythropoietins in oncology
The editorial article presents information about the problem of the use of erythropoietins in anemia in cancer patients in conjunction with the results of Cochrane systematic reviews the gold standard of the quality of evidence-based medical information.
Guardado en:
Autores principales: | Liliya E. Ziganshina, Irina V. Poddubnaia, Dmitrii A. Sychev |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
IP Habib O.N.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3f5c3e7add3f4c4e9db951e6070ae58f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
- Lord Thomas Cochrane
-
Frequency and characteristics of promissory conference abstracts, i.e. abstracts without results, accepted at Cochrane Colloquia 1994-2020
por: Darko Novak, et al.
Publicado: (2021) -
The role of doctors in smoking cessation: evidence from the Cochrane Library
por: Tim Lancaster
Publicado: (2021) -
A survey of eMedia-delivered interventions for schizophrenia used in randomized controlled trials
por: Naeem F, et al.
Publicado: (2017) -
Patient blood management in oncology in the Russian Federation: resolution to improve oncology care.
por: A. Hofmann, et al.
Publicado: (2020)